A B S T R A C T These experiments were carried out to demonstrate the usefulness of the perfused rabbit liver for studies of bile acid metabolism, and to determine the rate-limiting enzyme of bile acid synthesis. Rabbits were fed a semisynthetic diet, with or without the addition of 1% cholestyramine, under controlled conditions. At the end of 2-5 wk, the livers were removed and perfused for 2.5 hr employing various 'C-labeled precursors to measure de novo cholic acid synthesis. The livers were then analyzed for cholesterol, and the bile collected during the perfusion was analyzed for cholesterol and bile acids. Control bile contained, on the average, 0.34 mg of glycocholate, 7.4 mg of glycodeoxycholate, and 0.06 mg of cholesterol. After cholestyramine treatment of the donor rabbits, the bile contained 3.3 mg of glycocholate, 3.7 mg of glycodeoxycholate, and 0.05 mg of cholesterol. It was assumed that in cholestyraminetreated animals the enterohepatic circulation of the bile acids had been interrupted sufficiently to release the feedback inhibition of the rate-controlling enzyme of bile acid synthesis. Therefore, a given precursor should be incorporated into bile acids at a more rapid rate in livers of cholestyramine-treated animals, provided that the precursor was acted upon by the rate-controlling enzyme. It was found that the incorporation of acetate-'C, mevalonolactone-&4C, and cholesterol-14C into cholate was 5-20 times greater in the livers of cholestyraminetreated animals than in the controls. In contrast, there was no difference in the incorporation of 7a-hydroxycholesterolPC into cholate regardless of dietary pretreatment. It was concluded that given an adequate precursor pool, the 7a-hydroxylation of cholesterol is the rate-limiting step in bile acid formation.
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INTRODUCTION
The use of perfused livers in studies of biliary sterol and bile acid metabolism can be disappointing (1) because the bile obtained from livers of fasted animals, or from those fed ad lib., contains mainly "old" bile salt (glycodeoxycholic acid in the rabbit) which had returned to the liver via the enterohepatic circulation and was being "washed out" during the perfusion. Newly-synthesized bile salt (glycocholate in the rabbit) may be present in trace amounts only, or be absent altogether and thus such livers obtained from these animals are not very useful for studies of de novo bile acid formation. In contrast, the livers of rabbits maintained for 2 wk or longer on a diet containing 1% cholestyramine (a bile acid sequestering anion exchange resin) and maintained on an appropriate feeding schedule, should show active glycocholate synthesis during the perfusion, since bile acid production is stimulated by the action of the cholestyramine, which partially interrupts the enterohepatic circulation of the bile acids (2, 3) .
It seems safe to assume that the livers of control rabbits (not pretreated with cholestyramine) exhibit the same low rates of bile acid synthesis usually observed in animals with intact enterohepatic circulation ("inhibited livers") (4, 5) . Such livers then act as controls for comparison with preparations from cholestyramine-treated rabbits in which the enterohepatic circulation has been interrupted, resulting in high rates of bile acid synthesis ("noninhibited livers").
The pathway of bile acid biosynthesis from acetate may be represented in a greatly abbreviated form as follows: Acetate HMG-CoA > mevalonate -cholesterol 7a-hydroxycholesterol -> cholic acid.
If a given substrate, such as acetate, has to funnel through the rate-determining enzyme, the "noninhibited" livers will exhibit a faster incorporation rate of precursor to bile acid than the "inhibited" livers.
This concept is illustrated in Fig. 1 , where precursor 1 is acted upon by a rate-limiting enzyme while precursor 2 is not. If the rate-limiting enzyme is not inhibited, it operates at an increased velocity, and precursors 1 and 2 will be converted to bile acids at similar rapid rates. This is the case in cholestyramine-fed rabbits where the amount of bile salts reaching the liver is reduced. In contrast, in livers from normal rabbits with intact enterohepatic circulation, the rate-limiting enzyme is inhibited. As a result, the rate of incorporation of precursor 1 into cholic acid will be a rate which is dependent upon the presence of the circulating bile-acid pool (4) while the rate of incorporation of precursor 2 will not be affected.
To determine the rate-limiting step, studies were done using acetate-l-C, mevalonate-22C, cholesterol-4-`C, and 7a-hydroxycholesterol-4-14C as precursors. The bile samples from each experiment were assayed for de novo glycocholate synthesis in the manner described.
METHODS
Experimental animals. Male rabbits (New Zealand white), weighing between 1 and 2 kg, were maintained for 14-25 days on a pelleted, semisynthetic diet (General Biochemicals, 170920). The experimental animals received the same pellets containing cholestyramine (1% by weight).
Both groups were placed on a feeding schedule: food was removed from 9 a.m. to 5 p.m.; food was presented from 5 p.m. to 9 a.m.; water was available ad lib. The animals were operated upon between 10 and 11 a.m.; the perfusion was done immediately thereafter.
Liver perfusion. The technique for the rabbit liver perfusion has been described in detail (6) . Briefly, under light ether anesthesia, the portal vein was cannulated and perfusion started immediately from a reservoir. The bile duct and inferior vena cava were cannulated, the inferior vena cava was ligated above the diaphragm, and the liver removed. The gall bladder was ligated at its neck and the liver removed and mounted on a platform in a 370C humidified box. The outflow from the inferior vena cava was directed into a disc oxygenator and pumped back into the portal vein at a rate of 0.8-1.4 ml/g per min. The perfusate consisted of 2/3 rabbit blood with Krebs-Henseleit buffer containing 2-3 /Amoles of amino acid per 100 ml. Bile was collected from the cannulated bile duct at 30-or 60-min intervals. Tracer amounts of precursors were injected directly into the inflow tube connected to the portal vein. The perfusion was continued for 2-6 hr. At the end of the perfusion period, a portion of liver tissues (2-5 g) was frozen for storage and subsequent sterol analysis. Bile samples were stored at 4VC before analysis.
Due to the large size of rabbit liver (30-70 g), the volume of perfusate pumped into the portal vein is high and characterization of hepatic function is necessary. The following criteria were used: (a) bile flow, (b) urea production, (c) histological examination, (d) O consumption, and (e) 15 .0 mg of unlabeled cholesterol and the mixture was refluxed with 2.5 ml of acetic anhydride for 1 hr. After cooling, 5 ml of water and 2.5 ml of methanol were added, and the mixture was extracted three times with 12 ml of n-hexane. The pooled hexane extracts were washed once with saturated NaHCO3 solution, three times with water, and then dried over anhydrous Na2SO4, filtered, and evaporated to dryness at 50'C under nitrogen gas. The residue was dissolved in 3 ml of acetic acid (glacial) at 50'C, and 19 mg of CrOs were added slowly with constant stirring. After all of the CrO3 was added, stirring was continued for 30 min. 5 ml of water and 3.5 ml of methanol were added, and the reaction mixture was extracted three times with 10 ml of n-hexane. The hexane was washed with saturated NaHCO, solution, then with water, dried over anhydrous Na2SO4, filtered, and evaporated to dryness at 40'C under nitrogen gas. The product was purified by preparative TLC' on Silica Gel G (Brinkmann Instruments, Westbury, N. Y.) using ethyl acetate: benzene, 1: 3 (v/v), as solvent system (7-ketocholesterol acetate: R, 0.75). The 7-ketocholesterol acetate band was scraped off the plate, the acetate eluted with chloroform, and the solvent evaporated to dryness at room temperature under nitrogen gas.
The 7-ketocholesterol acetate was suspended in 6 ml of methanol at 14'C, and NaBH4 (2 moles/mole of ketone) was added slowly with stirring until the reaction mixture was clear. The reaction mixture was allowed to stand at room temperature overnight. This mixture contained both 7a-and 7,8-hydroxycholesterol-4-_4C acetates. These products were extracted with two portions of n-hexane: benzene (v/v), after the addition of an equal volume of water (6 ml) . The extracts were pooled, washed with water, dried 'Abbreviations used in this paper: GLC, gas-liquid chromatography; TLC, thin-layer chromatography. band containing the 7a-compound was scraped off the plate and eluted with chloroform, and the solvent was evaporated at room temperature under nitrogen gas. 7a-Hydroxycholesterol-4-"C was obtained by hydrolyzing the acetate for 30 min at 37'C in alcoholic KOH (6% KOH in 95% ethanol), adding an equal volume of water, extracting three times with n-hexane: benzene, 1: 1 (v/v), washing the extracts with water, drying over Na2SO4, filtering, and evaporating at room temperature under nitrogen gas. Purity was determined by TLC (single spot after spraying with 50% H2SO4), and by monitoring the distribution of "C counts on an unsprayed plate. The synthesis yielded 0.44 mg of 7a-hydroxycholesterol-4-14C (29 X 10' dpm) with a purity of 98-99%. The yield based on radioactivity was 11%. The yield based on weight of starting material was lower, due to the difficulty of obtaining an accurate weight of the final product.
Analytical methods. A portion of bile from each sample was deproteinized by the addition of 20 volumes of hot methanol. The tubes were cooled and centrifuged for 5 min, and the methanol was decanted from the protein precipitate and evaporated to dryness at 600 under air. The residues, containing the glycocholanoic acids, were hydrolyzed by autoclaving for 3 hr at 15 psi, 120'C, in 2 ml of water containing 10% KOH. The tubes were placed in ice and to each was added 1 ml methanol, 2 ml 6N HCl, and 5 ml H20. The free cholanoic acids were then extracted twice with 5 ml of fresh ethyl ether (9) . A portion of the free cholanoic acids was subj ected to TLC and the remainder was dissolved in 1 ml of methanol, 1 drop of conc. H2SO4 was added, and esterification was allowed to proceed at room temperature overnight. The methyl esters of the bile acids were extracted with two volumes of an ethyl ether: benzene mixture (2: 3, v/v) (10) , their radioactivity was determined, and portions were taken for quantitation by GLC. Thin-layer chromatography (TLC). The individual bile acids were separated on TLC as free acids, and the spots were removed from the plate for radioactivity assay. A suitable portion from each sample was spotted on Silica Gel G (Brinkmann Instruments, Inc.) and developed in acetic acid: isopropyl ether: isooctane [1: 1: 2] (11) as solvent system, which gave satisfactory separation of the following constituents: cholic acid (Rr 0.18), chenodeoxycholic acid (R, 0.41), deoxycholic acid (R, 0.49), and cholesterol (Rt 0.79).
Gas-liqutid chromatography (GLC)
The bile acid spots were removed with suction (12) and transferred to scintillation vials. The bile acids were eluted from the silica gel by adding 4 ml of ethanol (absolute) and heating the closed vial for 30 min at 60'C. The radioactivity of the samples was determined after the addition of 11 ml of 2,5-bis[2-(5-tert-butyl benzoxazolyl)]-thiophene solution (4 g/liter in toluene) in a liquid scintillation counter (Beckman LS 200 B) and corrected for background and quenching.
Hepatic cholesterol determination. 2 g of liver were
hydrolyzed in 25 ml of 95% ethanol containing 25% KOH by refluxing for 3 hr. Hepatic cholesterol was determined as the digitonide (13) . Radioactivity of the digitonide was determined by counting the precipitate on the filter paper in a Nuclear-Chicago low background planchet counter (Nuclear-Chicago Corp.), corrections being made for background and self-absorption.
Radiochemical purity of the biosynthesized bile acids.
Biles from livers perfused with labeled precursors were pooled, deproteinized, hydrolyzed, and the extracted free cholanoic acids were converted to their methyl esters. Cholic acid was isolated by preparative TLC, eluted with chloroform, and the solvent evaporated. To the residue containing the biosynthetic bile acid, 100 mg of authentic, unlabeled methyl cho'ate was added, and the mixture was recrystallized three times, yielding crystals of methyl cholate with a constant specific activity within the precision of measurement (Table I) . Free cholate and chenodeoxycholate were isolated from livers perfused with 7a-hydrocholesterol-4-"C in like manner. Chenodeoxycholate was crystallized as the free acid, and cholic acid as the methyl ester (Table I) . Again, the specific radioactivities remained constant during repeated recrystallizations. RESULTS It was first necessary to establish that the isolated, perfused rabbit liver was suitable for studies of bile acid biosynthesis. The experiments summarized in Table II show that in bile collected from the livers of fasted animals, glycodeoxycholate predominated, but some glycocholate was also present. When sodium acetate-1-2C was added to the perfusion fluid it was not incorporated into biliary bile acids to a measurable extent. This suggests that bile secreted by such livers contained largely "old" bile salts which had returned to the liver via the enterohepatic circulation and were being "washed out" during the perfusion. In contrast, the livers of rabbits maintained on the stock diet, or stock diet plus 1% cholestyramine, and on a controlled feeding schedule incorporated acetate-1-"C into biliary glycocholate (see Table IV ). Therefore, if it is assumed that the incorporation of sodium acetate-1-"C is a measure of de novo bile acid synthesis some of this glycocholate must have been synthesized during the perfusion period. It is apparent from Table IV that glycocholate was synthesized by the livers obtained both from the nonfasted controls and from cholestyramine-treated rabbits; however, synthesis was much greater when the liver donors had been pretreated with cholestyramine. As can be seen in Table II a total of 31 rabbits was studied. In addition to 10 rabbits maintained on a controlled feeding schedule on the stock diet (group B), and 15 rabbits on a controlled feeding schedule with 1% cholestyramine incorporated into the stock diet (group C), 6 rabbits were studied which were fed the stock diet and then fasted for 24 hr before perfusion (group A).
The six livers obtained from the rabbits in group A secreted from 0.0 to 1.58 mg of glycocholate during the perfusion period; however, there was no incorporation of 14C into this bile salt. This suggests that in the fasted rabbit (as in the rat), hepatic cholesterol biosynthesis is strongly inhibited so that insufficient cholesterol was available for bile acid production. At present it is not known whether in the rabbit fasting inhibits one or several steps on the pathway leading from acetate to cholic acid. The livers from the animals of groups B and C, maintained on the controlled feeding schedule, synthesized glycocholate during the perfusion, but the new synthesis was far greater in the livers from the cholestyramine-treated animals. The latter (group C), synthesized approximately 10 times the amount of glycocholate and incorporated considerably more radioactivity.
Data summarized in Table II for groups B and C are shown in greater detail in Figs. 2-9 . Bile volume was similar for both groups and remained linear with respect to time during the perfusion period of 21 hr (Fig.   2) . Glycocholate secretion is shown in Fig. 3 . The livers of cholestyramine-treated rabbits synthesized glycocholate at a far greater rate than the controls. The rate of radioactivity from acetate-1-14C into biliary and hepatic secretion of glycodeoxycholate (Fig. 4) , on the other hand, was significantly greater in the livers from con- (Fig. 5) .
Typical experiments dealing with de novo synthesis of glycocholate as measured by incorporation of "C precursors are shown in Figs. [6] [7] [8] [9] . Sodium acetate-1-"C ( Fig. 6) , D,L-mevalonolactone-2-"C (Fig. 7) , and cholesterol-4-"C ( Fig. 8) were incorporated at significantly greater rates into glycocholate by livers of cholestyramine-treated rabbits. With 7a-hydroxycholesterol-4-"C as precursor, cholestyramine pretreatment had no effect on the incorporation of "C into glycocholate (Fig. 9) .
The radioactivity data obtained in these experiments are summarized in Tables IV-VII. When acetate-1-"C, mevalonate-2-"C, or cholesterol-4-14C (Tables IV-VI) were used as precursors, the de novo synthesis of glycocholate, measured either by weight or by radioactivity incorporation, was significantly increased in the livers of cholestyramine-treated rabbits. The incorporation of cholesterol was also increased by cholestyramine pretreatment, but no consistent effect ascribed to cholestyramine was observed in the mevalonate-2-14C and cholesterol-4-15C experiments. However, when 7a-hydroxycholesterol-4-14C was used as the precursor (Table VII) , livers from both control and cholestyramine-pretreated rabbits showed almost identical rates of incorporation of radioactivity into glycocholato (Fig. 9 ). This indicates that 7a-hydroxycholesterol does not channel through the rate-controlling enzyme (Fig. 1) . 7a-Hydroxycholesterol-4-"C does not serve as a precursor of hepatic or biliary cholesterol. DISCUSSION To our knowledge, this is the first time that the isolated, perfused rabbit liver has been employed in studies of bile acid synthesis. An identical preparation had been employed previously in studies of albumin synthesis and had been considered suitable for this purpose by currently accepted standards (6) . In the present experiments, a number of-additional criteria (glycocholate production and incorporation of 14C from labeled precursors) were used to establish that this preparation is suitable for studies of de novo bile-acid synthesis. In previous liver perfusion studies-mainly carried out in rats (1, 14, 15) , fasted or fed ad lib.-"old" bile salts, which had returned to the liver via the enterohepatic circulation before perfusion of the liver, were the major bile-salt components of the bile.
In the present study, two procedures were employed to make sure that the isolated, perfused rabbit liver produced bile acids de novo. The control animals were fed a semisynthetic diet for a limited period (from 5 p. m. to 9 a. m.) each day. A diurnal cycle of cholesterol and bile acid synthesis (16) label into chenodeoxycholate when 7a-hydroxycholesterol was the precursor is not understood, but it may be related to the fact that the intermediate common to both cholic and chenodeoxycholic acid, namely 3a,7a-dihydroxycholest-4-en-3-one, is not readily available to the 12a-hydroxylase for further metabolism to cholic acid. Thus, there would be greater channeling into the chenodeoxycholate pathway.
By use of the various "C-labeled precursors and comparison of the rates of incorporation into bile acids in the livers from control animals (those fed the stock diet) and livers from experimental animals (those fed the stock diet with 1% cholestyramine), it is possible to deduce that the rate-limiting step of bile acid biosynthesis is the 7a-hydroxylation of cholesterol. The livers from the control rabbits are representative of an intact enterohepatic circulation and are considered to be inhibited. This is shown by their relatively low rates of synthesis as measured by the incorporation of "C-labeled acetate, mevalonate, and cholesterol into bile acid (Tables IV-VI) . In contrast, 7a-hydroxycholesterol-4-"C was incorporated at similar rates in livers from both control and experimental rabbits (Table VII) , indicating that 7a-hydroxycholesterol is not acted upon by the rate-limiting enzyme. This is in agreement with During last hour of perfusion period (not calculated from totals). § 3 ug dissolved in 1 ml saline and given as single injection at 0 min. 11 6 pg dissolved in 8 ml of saline and infused at rate of 3 ml per hr from 0 to 120 min. similar studies in the bile fistula rat (18) , where it was During the first 2 hr of a 5k hr perfusion, 6 .12 mg of shown that the steps on the pathway beyond 7a-hy-7a-hydroxycholesterol-4-'4C was added to the perfusate droxycholesterol were not longer under the control of the at a rate of 3.1 mg per hr, and 2.1 mg was converted to circulating bile acid pool.
glycocholate. The per cent utilization of a given emulIn the experiments with cholesterol-4-"C and 7a-hy-sion may depend largely on the physical state of the droxycholesterol-4-14C, these water-insoluble tracers were dispersed sterol, and this is likely to vary for any given "solubilized" with Tween 20. As a result these non-emulsion. Even with a water-soluble substrate (e.g. physiological "solutions" were only partially utilized for mevalonolactone-2-'4C) there may exist a problem of bile acid synthesis. This is presumably due to the fact substrate penetration, and this may explain the prothat only a certain fraction of the "solubilized" sterol nounced lag-period seen with this tracer (Fig. 7) . reaches the intracellular site of bile acid synthesis;
The data summarized in Tables III-VII illustrate a from 13 to 60% of the administered tracer was actually problem common to all tracer studies in which the pool recovered from the perfusion fluid. It can be seen from size and specific activity of a precursor are not availexperiment 21 (Table VII) , however, that this does able for assay. In Tables III and IV when acetatenot represent an inherent limitation of the livers to 1-`C was used as the precursor, the final specific acmetabolize larger amounts of 7a-hydroxycholesterol. tivity of biliary cholesterol was usually considerably Specific activity during final hour of perfusion (not calculated from totals). § S pg solubilized in 20% Tween (0.1 ml) and 0.9 ml of 0.9% saline and given as single injection at 0 min. 4-"C). The data suggest that the hepatic precursor pools for biliary cholesterol and glycocholate vary not only from animal to animal but are in addition altered by cholestyramine administration. For example, when cholesterol-4-14C was used as the precursor, the specific activity of biliary glycocholate was higher in the control livers than in those of donor rabbits pretreated with cholestyramine (Table VI) . However, the amounts of glycocholate formed were many times greater in the latter than in the controls. This would suggest that the specific hepatic cholesterol pool for bile acid synthesis was increased in the cholestyramine experiments, thus diluting the available cholesterol-"C at the site of synthesis. While the data reported here reflect quantitative changes in the rates of de novo bile acid synthesis they cannot be used to quantitate the magnitude of the precursor pools. In the experiments with 7a-hydroxycholesterol it can be deduced that the pool size must be small or that the pool turns over very rapidly, but more accurate estimates must await the development of improved techniques.
It was observed that incorporation of acetate-1-"C into hepatic cholesterol was increased by cholestyramine pretreatment (Table IV) . This suggests, but does not prove, that bile acids inhibit hepatic HMG-CoA reductase. Thus, Weis and Dietschy (19) have proposed that the effect may be indirect and that it is exerted via the enterolymphatic circulation of cholesterol. Presumably, greater quantities of cholesterol reach the liver of control animals where more bile acid is present in the intestinal tract to favor cholesterol absorption. Therefore, the inhibitory substance may be cholesterol rather than bile acid.
